跳至主要内容
临床试验/NCT01225458
NCT01225458终止不适用

Behaviour and Cognitive Evaluation for Dialysis Elderly Patients (BCDE)

Centre Hospitalier Universitaire de Nice1 个研究点 分布在 1 个国家目标入组 48 人开始时间: 2008年7月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
终止
入组人数
48
试验地点
1
主要终点
death

研究概览

简要总结

The trial is a multicenter, prospective, randomized, open study. A total of 500 elderly patients aged over 75 years with renal insufficiency stage 5 will be included in the study after signed informed consent. Patients will be randomized 1/1 in two arms : 250 patients in the "exclusive nephrology follow-up" arm will continue their usual follow-up; 250 patients in the "geriatric follow-up" arm will have both their usual nephrology follow-up and a geriatric follow-up.

The aim of the study is to determine if a systematized gerontologist evaluation delay the occurrence of a composite primary endpoint : death, dementia, depression and severe dependency. The hypothesis is that the functional and vital prognosis of a patient with renal insufficiency depends not only on common and classical factors but also on cognitive and psychological functions and dependence, particularly in elderly patients.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Prevention
盲法
None

入排标准

年龄范围
75 Years 至 —(Older Adult)
性别
All
接受健康志愿者
否

入选标准

  • •Patients aged of 75 years old or more,
  • •Chronic kidney disease stage 5 defined by :
  • •either an estimated GFR (MDRD) ≤ 15ml/mn/1,73 m² in a non-dialysis patient with a nephrology follow-up > 3 months ("Pre-dialysis cohort"),
  • •or a dialysis treatment started for more than 3 months and less than one year, after a pre-dialysis follow-up > 3 months ("post-dialysis cohort"),
  • •Signed and dated informed consent.

排除标准

  • •Moderately severe to severe dementia (MMS ≤ 15),
  • •Major depression and/or GDS-15 > 10/15,
  • •Severe dependency (ADL < 3/6).,
  • •Psychosis, mutism or aphasia,
  • •Malignancy or any pathology with life expectancy < one year.
  • •Ongoing specialized geriatric care

研究组 & 干预措施

exclusive nephrology follow-up

Placebo Comparator

250 patients will be included and randomized in the "exclusive nephrology follow-up" arm will continue their usual nephrology follow-up with consultations every 6 months during 3 years for dialysis patients or with consultations every 6 months before dialysis, 3 months after starting dialysis and every 6 months for a total duration of 3 years for non-dialysis patients. In addition to their nephrology consultations, patients will benefit from a geriatric evaluation with MMS, GDS and ADL scoring.

干预措施: shorter tests (Other)

exclusive nephrology follow-up

Placebo Comparator

250 patients will be included and randomized in the "exclusive nephrology follow-up" arm will continue their usual nephrology follow-up with consultations every 6 months during 3 years for dialysis patients or with consultations every 6 months before dialysis, 3 months after starting dialysis and every 6 months for a total duration of 3 years for non-dialysis patients. In addition to their nephrology consultations, patients will benefit from a geriatric evaluation with MMS, GDS and ADL scoring.

干预措施: initial complete geriatric tests (Other)

geriatric follow-up

Experimental

250 patients will be included and randomized in the "geriatric follow-up" arm. They will continue their usual nephrology follow-up with consultations every 6 months during 3 years for dialysis patients or with consultations every 6 months before dialysis, 3 months after starting dialysis and every 6 months for a total duration of 3 years for non-dialysis patients.

About geriatric evaluation Patients randomized in this arm will also have more complete tests to evaluate cognitive functions (memory, language and movements), psychological functions (depression and anxiety) and dependency in activities of daily living. Other tests will allow evaluate vision, audition, mobility and nutritional status.

干预措施: shorter tests (Other)

geriatric follow-up

Experimental

250 patients will be included and randomized in the "geriatric follow-up" arm. They will continue their usual nephrology follow-up with consultations every 6 months during 3 years for dialysis patients or with consultations every 6 months before dialysis, 3 months after starting dialysis and every 6 months for a total duration of 3 years for non-dialysis patients.

About geriatric evaluation Patients randomized in this arm will also have more complete tests to evaluate cognitive functions (memory, language and movements), psychological functions (depression and anxiety) and dependency in activities of daily living. Other tests will allow evaluate vision, audition, mobility and nutritional status.

干预措施: initial complete geriatric tests (Other)

geriatric follow-up

Experimental

250 patients will be included and randomized in the "geriatric follow-up" arm. They will continue their usual nephrology follow-up with consultations every 6 months during 3 years for dialysis patients or with consultations every 6 months before dialysis, 3 months after starting dialysis and every 6 months for a total duration of 3 years for non-dialysis patients.

About geriatric evaluation Patients randomized in this arm will also have more complete tests to evaluate cognitive functions (memory, language and movements), psychological functions (depression and anxiety) and dependency in activities of daily living. Other tests will allow evaluate vision, audition, mobility and nutritional status.

干预措施: follow-up complete geriatric tests (Other)

结局指标

主要结局

death

时间窗: every 6 month for 3 years since inclusion

occurrence of a severe dementia (MMS < 10)

时间窗: every 6 month for 3 years since inclusion

major depression detected by GDS-15 > 10/15 and confirmed by DSM-IV criteria

时间窗: every 6 month for 3 years since inclusion

severe dependency (ADL < 3/6)

时间窗: every 6 month for 3 years since inclusion

次要结局

  • cardiovascular morbidity and mortality(every 6 month for 3 years since inclusion)
  • cognitive, psychic and autonomy scores(every 6 month for 3 years since inclusion)
  • bone fracture(every 6 month for 3 years since inclusion)
  • nutritional parameters(every 6 month for 3 years since inclusion)
  • dialysis parameters(every 6 month for 3 years since inclusion)
  • biological follow-up of chronic kidney disease including haemoglobin level(every 6 month for 3 years since inclusion)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验